Prognose

Das durchschnittliche Kursziel der Analysten beträgt +7,59€(+15,17%). Der Median liegt bei +7,59€(+15,17%).

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

Toyota ($TM) | XPENG ($XPEV) | Innoviz ($INVZ) | Volkswagen ($VWAGY) Vicarious Surgical ($RBOT)
Welcome to the Green Stock News brief for Tuesday May 13th. Here are today's top headlines: Toyota (NYSE: TM) has unveiled its 2026 bZ Battery Electric Vehicle, featuring improved range, including a new 74.7-kWh battery offering up to 314 miles of range.» Mehr auf youtube.com
Vicarious Surgical Inc. (RBOT) Q1 2025 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT ) Q1 2025 Results Conference Call May 12, 2025 4:30 PM ET Company Participants Webb Campbell - Investor Relations Adam Sachs - Co-Founder and CEO Sarah Romano - CFO Conference Call Participants Eric Anderson - TD Cowen Operator Hello everyone, and welcome to the Vicarious Surgical's 2025 First Quarter Earnings Call. My name is Nadia, and I'll be coordinating the call today.» Mehr auf seekingalpha.com
Vicarious Surgical Reports First Quarter 2025 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the first quarter ended March 31, 2025. Management will host a corresponding conference call at 4:30 p.m. ET today, May 12, 2025. “Following years of meticulous work to develop and advance our surgical system and proprietary decoupled ac.» Mehr auf businesswire.com

Im letzten Quartal hatte Vicarious Surgical einen Umsatz von 0,00€ und ein Nettoeinkommen von −14,23 Mio€